← Back to Search

Behavioural Intervention

Cognitive Training App for Chemobrain

N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
and age >21 years old
newly diagnosed gynecologic malignancy (uterine, cervical, ovarian, primary peritoneal, vulvar, or vaginal) and undergoing chemotherapy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from initiation of chemotherapy through 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if using a mobile training app can help reduce cognitive decline in gynecologic cancer patients undergoing treatment. The app will be evaluated by a team of experts to see its effectiveness in

Who is the study for?
This trial is for adults over 21 with a new diagnosis of gynecologic cancer (like uterine, cervical, ovarian) who are starting chemotherapy and own a smartphone or tablet. It's not suitable for those who can't use the cognitive training app.
What is being tested?
The study tests whether a mobile app designed for cognitive training can help reduce 'chemobrain' symptoms—cognitive issues that often affect cancer patients receiving treatments like chemotherapy.
What are the potential side effects?
Since this trial involves using an application rather than medication, traditional side effects are not expected. However, users may experience frustration or fatigue from regular use of the cognitive exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 21 years old.
Select...
I have a new diagnosis of a gynecologic cancer and am starting chemotherapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from initiation of chemotherapy through 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and from initiation of chemotherapy through 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Neurocognitive function

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MOBILE COGNITIVE TRAINING APPExperimental Treatment1 Intervention
These patients will undergo neuropsychology evaluation and use the cognitive mobile training application
Group II: OBSERVATIONActive Control1 Intervention
PATIENTS WILL PARTICIPATE IN THE NEUROPSYCHOLOGY EVALUATION BUT WILL NOT USE THE COGNITIVE MOBILE TRAINING APPLICATION.

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,656 Previous Clinical Trials
2,444,311 Total Patients Enrolled
~41 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top